Alzheimer’s Disease - Pharma

Relevant Publications

Integrative analysis of microRNA-mediated mitochondrial dysfunction in hippocampal neural progenitor cell death in relation with Alzheimer’s disease

Issue Release: 2023

The Association between Party Horn Use and Respiratory Function in Patients with Dementia: An Experimental Study.

Issue Release: 2023

A molecular view of human amyloid-β folds.

Issue Release: 2022

The PET tracer [C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer\'s disease.

Issue Release: 2022

Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer\'s disease.

Issue Release: 2022

Peripheral Aβ acts as a negative modulator of insulin secretion.

Issue Release: 2022

T-DAV: Action naming test with videos. Development, validation and standardization

Issue Release: 2022

Cryo-EM structures of amyloid-β 42 filaments from human brains.

Issue Release: 2022

Apolipoprotein E polymorphisms in adults over 60 years of age with mild cognitive impairment and Alzheimer’s disease in different Venezuelan populations

Issue Release: 2022

Cognitive Functioning and Nail Salon Occupational Exposure among Vietnamese Immigrant Women in Northern California.

Issue Release: 2022

Retinal Microvascular Dysfunction Occurs Early and Similarly in Mild Alzheimer\'s Disease and Primary-Open Angle Glaucoma Patients.

Issue Release: 2022

Diffusion MRI-guided theta burst stimulation enhances memory and functional connectivity along the inferior longitudinal fasciculus in mild cognitive impairment.

Issue Release: 2022

The future of Parkinson\'s disease research: A new paradigm of human-specific investigation is necessary… and possible.

Issue Release: 2022

Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer\'s disease.

Issue Release: 2022

Therapeutic news in Alzheimer’s disease: soon a disease-modifying therapy?

Issue Release: 2022

Errorless learning in cognitive rehabilitation of Alzheimer’s disease and primary progressive aphasia

Issue Release: 2022

Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study.

Issue Release: 2022

The role of steroid hormones in the neurodegenerative diseases

Issue Release: 2022

MEF2C ameliorates learning, memory, and molecular pathological changes in Alzheimer’s disease in vivo and in vitro

Issue Release: 2022

An aggregation inhibitor specific to oligomeric intermediates of Aβ42 derived from phage display libraries of stable, small proteins.

Issue Release: 2022

How Does Pharma Play a Role in Chronic Conditions?

What are Contract Research Organizations (CROs)?

What Role Do Pharmacists Play in Patient Education?

How Does Cellular Stress Impact Drug Development?

How Does the Patent System Affect Generic Competition?

How Do Pharmacists Contribute to Patient Care?

How Can Pharmacists Contribute to Transitional Care?

What are the Regulatory Requirements for Generic Drugs?

How Do Collaborative Care Models Work?

How Long Does the Approval Process Take?

Partnered Content Networks

Relevant Topics